drugset / Trial / NCT06729970

A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants

NCT06729970

Phase 1 Completed 133 enrolled Karuna Therapeutics, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of lithium, valproic acid, and lamotrigine on the single-dose pharmacokinetics (PK) of KarXT and the effect of KarXT on the single-dose PK of lithium, valproic acid, and lamotrigine in healthy participants.

Timeline

Start
2024-12-26
Primary completion
2026-01-23
Completion
2026-01-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule
Subject Lithium Unknown
Subject Valproic Acid Small molecule
Subject Xanomeline/Trospium Chloride Unknown

Indications

No indication recorded.